These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21973091)

  • 1. Targeted drug therapy: the platelet side.
    Lhermusier T; Van Rothem J; Garcia C; Gratacap MP; Payrastre B
    Platelets; 2011; 22(7):479-84. PubMed ID: 21973091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet Signaling Pathways and New Inhibitors.
    Grover SP; Bergmeier W; Mackman N
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):e28-e35. PubMed ID: 29563117
    [No Abstract]   [Full Text] [Related]  

  • 3. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
    Faivre S; Djelloul S; Raymond E
    Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal vein occlusion disease and platelet activation: will antiplatelet therapy be a promising therapeutic strategy for patients with retinal vein occlusion disease in the future?
    Fateh-Moghadam S; Gawaz M
    Thromb Haemost; 2007 Feb; 97(2):169-70. PubMed ID: 17264941
    [No Abstract]   [Full Text] [Related]  

  • 5. Acquired platelet antagonism: off-target antiplatelet effects of malignancy treatment with tyrosine kinase inhibitors.
    Tullemans BME; Heemskerk JWM; Kuijpers MJE
    J Thromb Haemost; 2018 Sep; 16(9):1686-1699. PubMed ID: 29975003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation.
    Covic L; Misra M; Badar J; Singh C; Kuliopulos A
    Nat Med; 2002 Oct; 8(10):1161-5. PubMed ID: 12357249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New assignments for multitasking signal transduction inhibitors.
    Zhang Z; Meier KE
    Mol Pharmacol; 2006 May; 69(5):1510-2. PubMed ID: 16497876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet Function in Cardiovascular Disease: Activation of Molecules and Activation by Molecules.
    Khodadi E
    Cardiovasc Toxicol; 2020 Feb; 20(1):1-10. PubMed ID: 31784932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy.
    Tautz L; Senis YA; Oury C; Rahmouni S
    Bioorg Med Chem; 2015 Jun; 23(12):2786-97. PubMed ID: 25921264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recently recognized platelet agonists.
    Morrell CN; Maggirwar SB
    Curr Opin Hematol; 2011 Sep; 18(5):309-14. PubMed ID: 21730836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of platelet activation-inhibitory drugs.
    Rao GH; Rao AT
    Indian J Physiol Pharmacol; 1994 Apr; 38(2):69-84. PubMed ID: 8063366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatic discovery of novel bioactive peptides.
    Edwards RJ; Moran N; Devocelle M; Kiernan A; Meade G; Signac W; Foy M; Park SD; Dunne E; Kenny D; Shields DC
    Nat Chem Biol; 2007 Feb; 3(2):108-12. PubMed ID: 17220901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of quercetin on platelet spreading on collagen and fibrinogen and on multiple platelet kinases.
    Navarro-Núñez L; Lozano ML; Martínez C; Vicente V; Rivera J
    Fitoterapia; 2010 Mar; 81(2):75-80. PubMed ID: 19686810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of platelet activation and development of antiplatelet agents].
    Cazenave JP; Gachet C; Lanza F
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1501-6. PubMed ID: 9092410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.
    Gollob JA; Wilhelm S; Carter C; Kelley SL
    Semin Oncol; 2006 Aug; 33(4):392-406. PubMed ID: 16890795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-protein-coupled receptors as signaling targets for antiplatelet therapy.
    Smyth SS; Woulfe DS; Weitz JI; Gachet C; Conley PB; Goodman SG; Roe MT; Kuliopulos A; Moliterno DJ; French PA; Steinhubl SR; Becker RC;
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):449-57. PubMed ID: 19023091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.
    Remsing Rix LL; Rix U; Colinge J; Hantschel O; Bennett KL; Stranzl T; Müller A; Baumgartner C; Valent P; Augustin M; Till JH; Superti-Furga G
    Leukemia; 2009 Mar; 23(3):477-85. PubMed ID: 19039322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pennogenin tetraglycoside stimulates secretion-dependent activation of rat platelets: evidence for critical roles of adenosine diphosphate receptor signal pathways.
    Cong Y; Liu X; Kang L; Yu Z; Zhao Z; Li J; Ma B; Cong Y
    Thromb Res; 2012 May; 129(5):e209-16. PubMed ID: 22401797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid beta peptide-activated signal pathways in human platelets.
    Shen MY; Hsiao G; Fong TH; Chen HM; Chou DS; Lin CH; Sheu JR; Hsu CY
    Eur J Pharmacol; 2008 Jul; 588(2-3):259-66. PubMed ID: 18511035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.